BioMarin Pharmaceutical Inc. is adding Dr. Robert Plenge to its Board of Directors starting September 10, 2026.

Sep 14, 2026, 10:12 AM ETNew bossRead the original at sec.gov

Neutral

BioMarin appointed Robert Plenge to its board and Science and Technology Committee and granted $400,000 in RSUs. The filing reads as a routine governance update and does not alter the company's business prospects.

BMRN · BioMarin Pharmaceutical Inc.

AI read · Neutral

The AI's read

BioMarin added Robert Plenge, M.D., Ph.D., to its board and its Science and Technology Committee. The filing also shows a $400,000 RSU grant and no related-party transaction, so this reads as a routine governance update and does not change BioMarin's business prospects.

Get alerts for BMRN

Follow BioMarin Pharmaceutical Inc. (BMRN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BMRN

Free on the App Store and Google Play, or on the web.